Stericycle Inc (SRCL) was Downgraded by Imperial Capital to ” Underperform” while Lowering the Price Target of the company shares to $ 93.50 from a previous price target of $100 . Earlier the firm had a rating of “In-line ” on the company shares. Imperial Capital advised their investors in a research report released on Jul 29, 2016.
Many Wall Street Analysts have commented on Stericycle Inc. Company shares were Reiterated by Imperial Capital on May 26, 2016 to “In-line”, Firm has raised the Price Target to $ 100 from a previous price target of $95 .Shares were Reiterated by Wedbush on May 9, 2016 to “Neutral” and Lowered the Price Target to $ 100 from a previous price target of $112 .Shares were Reiterated by Imperial Capital on May 2, 2016 to “In-line” and Lowered the Price Target to $ 95 from a previous price target of $115 .
On the company’s financial health, Stericycle Inc reported $1.18 EPS for the quarter, based on the information available during the earnings call on Jul 28, 2016. Analyst had a consensus estimate of $1.18. The company had revenue of $891.60 million for the quarter, compared to analysts expectations of $911.39 million. The company’s revenue was up 24.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.14 EPS.
Stericycle Inc closed down -0.55 points or -0.52% at $105.93 with 9,99,812 shares getting traded on Thursday. Post opening the session at $106.45, the shares hit an intraday low of $105.365 and an intraday high of $106.815 and the price fluctuated in this range throughout the day.Shares ended Thursday session in Red.
In a different news, on Jul 11, 2016, Mark C Miller (director) sold 34,835 shares at $104.52 per share price. According to the SEC, on Feb 23, 2016, Daniel Ginnetti (Chief Financial Officer) sold 17,184 shares at $110.75 per share price. On Dec 15, 2015, John P Schetz (EVP & General Counsel) sold 1,190 shares at $116.34 per share price, according to the Form-4 filing with the securities and exchange commission.
Stericycle Inc. is engaged in the business of providing regulated and compliance solutions to healthcare and commercial businesses. The Companys solutions include the collection and processing of specialized waste for disposal and a variety of training consulting recall/return communication and compliance services which include training consulting inbound/outbound communications data reporting and other regulatory compliance services. The Company operates regulated waste management networks in the United States Argentina Brazil Canada Chile Ireland Japan Mexico Portugal Romania South Korea Spain and the United Kingdom. The Company operates through two segments: United States and International. The Companys networks include a total of 181 processing facilities 214 transfer sites and 97 other service facilities. Its regulated waste processing technology is primarily autoclaving. The Company also uses incineration and electro-thermal-deactivation system (ETD).